“…In the five reported cases in which it was indicated that the tumor had high mitotic activity (45 mitoses per 10 HPF), including the presence of atypical mitoses, the patients had a shorter survival (5-11 months, mean 8); 2,3,5 while in five of those cases in which it was stated that the mitotic figures were rare or uncommon (o3 per 10 HPF), two patients died of disease 17 and 30 months after diagnosis, respectively, 14 and three were alive at the time of publication 12, 20, and 32 months after diagnosis, respectively. 9,12,18 These findings are comparable to those of the present investigation in that those tumors with a high number of mitoses (45 per 10 HPF), a decrease in cell cohesion, highly atypical nuclei that vary in their size and often contain cytoplasmic inclusions, and large, sometimes multiple nucleoli tend to behave in a more aggressive manner than those in which the mitotic activity was low, the cells were more uniform and more cohesive, and the nuclei exhibited less atypia. In the present series, 7 of the cases (Cases 1, 2, 6, 7, 8, 13, and 15) that were considered to belong to the first group died of disease 4-17 months (mean, 7 months) after diagnosis, while 9 of the 10 cases ( Cases 5,12,14,16,17,18,19,20, and 21) that were considered to belong to the second group died of disease 6-62 months (mean, 22 months) after diagnosis and the remaining patient (Case 4) was alive 25 months following diagnosis (Table 3).…”